Worldwide commercialization of an HIV diagnostic assay.
We developed a comprehensive strategic roadmap for a large life sciences company seeking to solidify its drug discovery business.
Working with a new player with a target therapeutic in a particular solid tumor indication, we helped our client prioritize markets and developed a set of tactics to address adoption barriers that were unique to each country
Faced with a large list of test menu options for a new diagnostic detection technology, we helped our client to optimize the roll-out of these options into several phases to drive maximum placements and revenue overtime.
